An Open Label, Single Dose, Randomized, Two-Period, Two-Way Crossover Study to Evaluate the Pharmacokinetics and Bioequivalence of Vycavert Tablets Compared to Norco Tablets in Healthy Subjects.

Trial Profile

An Open Label, Single Dose, Randomized, Two-Period, Two-Way Crossover Study to Evaluate the Pharmacokinetics and Bioequivalence of Vycavert Tablets Compared to Norco Tablets in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Feb 2012

At a glance

  • Drugs Hydrocodone/paracetamol (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Feb 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
    • 07 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Jan 2012 Planned End Date changed from 1 Dec 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top